Key result
Oral trivalent polio vaccine administration in a cloistered community lacks specific quantitative safety findings.
Why the study?
Does oral trivalent poliomyelitis vaccine cause reversion to virulence in a cloistered community?
Observational
Does oral trivalent poliomyelitis vaccine cause reversion to virulence in a cloistered community?
Oral administration of trivalent poliomyelitis vaccine appears safe without clinical evidence of reversion to virulence.
Supports safety of oral polio vaccine in isolated groups; leaves open generalizability and reversion risk in broader populations.
DURING the ten-year period since the first patient was deliberately fed a culture of attenuated poliomyelitis virus1 until the present time, probably more than 10,000,000 human beings have been fed a similar culture of poliovirus or mixtures of polioviruses. Moreover, numerous other such immunization programs are being instituted in much of the Western world, indicating the relative, if not utter, safety of such procedures. Despite some laboratory evidence to the contrary,2 the theoretical possibility of reversion to virulence has not been observed as a clinical phenomenon. Most of the published observations have been made among children and young adults, especially . . .
No takes yet. Share an insight, caveat, or question.
Ruegsegger et al. (1960) conducted an observational in Poliomyelitis. Oral Trivalent Poliomyelitis Vaccine was evaluated. Oral trivalent poliomyelitis vaccine administration was described in a cloistered community, though the truncated abstract lacks specific quantitative findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: